[1]
F. M. Szymański, “Aldosterone antagonists in the treatment of poorly controlled and resistant arterial hypertension – results of the newest PATHWAY-2 trial”, KardiolwPrakt, vol. 9, no. 4, pp. 12-16, Dec. 2015.